Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 68788-8471

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 68788-8471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclobenzaprine HCl Tablets Usp 5mg (E4e8bab3 C5e7 4d2b 9692 Ee6c6799b120 00)

Label for Cyclobenzaprine HCl Tablets, USP 5 mg manufactured by Rubicon Research Private Limited and distributed by Preferred Pharmaceuticals, Inc. The label identifies the product as generic for Flexeril, specifies it is a film-coated tablet, and includes storage instructions and warnings. The label also contains bilingual directions for use in English and Spanish on a yellow background.*

FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Chemical structure of cyclobenzaprine hydrochloride, showing a tricyclic ring system connected to an amino-substituted side chain with a hydrochloride salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.